rawfin.tv
Biotech Firm Odyssey Raises $279 Million in Upsized US IPO
MarketsstocksAI Generated

Biotech Firm Odyssey Raises $279 Million in Upsized US IPO

By rawfin.tv Markets Desk||1 min read|AI-assisted · Methodology

Biotech company Odyssey successfully raised $279 million in an upsized initial public offering in the US. The IPO marks a significant capital infusion for the firm, enabling further development and expansion.

BiotechnologyIPOCapital MarketsHealthcareFundraising

Related Articles

S&P 500 Faces 30% Drop in $20T AI Bust, TS Lombard Warns

S&P 500 Faces 30% Drop in $20T AI Bust, TS Lombard Warns

stocks
Nasdaq Smashed and Dow Drops as Oil Jumps on Geopolitical Tensions

Nasdaq Smashed and Dow Drops as Oil Jumps on Geopolitical Tensions

stocks
Asian Equities Plunge And Bitcoin Retreats As Chinese Markets Enter Bear Territory

Asian Equities Plunge And Bitcoin Retreats As Chinese Markets Enter Bear Territory

stocks
Barclays Workforce Trimmed 5% as Bank Increases Focus on AI

Barclays Workforce Trimmed 5% as Bank Increases Focus on AI

stocks